Insider Trading History of Hoenlein Malcolm

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Hoenlein Malcolm since 2005. The trader's CIK number is 1294517. At the time of the last reporting, Hoenlein Malcolm was the Officer of Fortress Biotech, Inc.. (stock ticker symbol FBIO). Also see all insider trading activities at Fortress Biotech, Inc..

Note that in the past Hoenlein Malcolm also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Keryx Biopharmaceuticals Inc (KERX) by Hoenlein Malcolm

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 KERX 0 $0 7,000 $92,470 5,000 $9,600
2001 KERX 2,000 $19,240 0 $0 0 $0

Yearly summary of insider trading at Fortress Biotech, Inc. (FBIO) by Hoenlein Malcolm

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 FBIO 16,667 $300,006 0 $0 0 $0
2014 FBIO 25,000 $40,250 0 $0 0 $0


Insider trading activities at 2 companies by Hoenlein Malcolm:

1. Keryx Biopharmaceuticals Inc (KERX)

2. Fortress Biotech, Inc. (FBIO)

Table 1. Insider trading of Keryx Biopharmaceuticals Inc (KERX) by Hoenlein Malcolm

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-12-29 KERX Sale 7,000 13.21 92,470
2006-12-29 KERX Option Ex 5,000 1.92 9,600
2001-02-02 KERX Buy 2,000 9.62 19,240

Table 2. Insider trading of Fortress Biotech, Inc. (FBIO) by Hoenlein Malcolm

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-08-26 FBIO Buy 16,667 18.00 300,006
2014-11-06 CNDO Buy 25,000 1.61 40,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hoenlein Malcolm (Officer of Fortress Biotech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.